Blueprint Medicines Corporation (BPMC) financial statements (2022 and earlier)

Company profile

Business Address 45 SIDNEY STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:4771,550548494673268163
Cash and cash equivalents2106851146840052163
Short-term investments267187370426273162 
Other undisclosed cash, cash equivalents, and short-term investments 67864(0)054 
Restricted cash and investments   0  0
Receivables2571    
Inventory, net of allowances, customer advances and progress billings229     
Inventory229     
Other undisclosed current assets30(638)(32)612(48)8
Total current assets:554928517500686220170
Noncurrent Assets
Operating lease, right-of-use asset906873
Property, plant and equipment313438302467
Long-term investments and receivables55867864  54 
Long-term investments55867864  54 
Restricted cash and investments5555511
Other noncurrent assets156106111
Total noncurrent assets:6987911914030628
TOTAL ASSETS:1,2521,718708540716283179
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities130110935534149
Accounts payable8453422
Accrued liabilities122106895231126
Deferred revenue12136
Debt  7 233
Deferred compensation liability      0
Deferred revenue and credits5116
Contract with customer, liability4
Other undisclosed current liabilities88 2211
Total current liabilities:15013110660432919
Noncurrent Liabilities
Long-term debt and lease obligation1038289  24
Long-term debt, excluding current maturities     24
Operating lease, liability1038289
Liabilities, other than long-term debt2836484834379
Deferred revenue and credits34379
Deferred revenue252940
Contract with customer, liability43
Deferred compensation liability, classified      0
Deferred rent credit   5
Other liabilities3780000
Other undisclosed noncurrent liabilities   13   
Total noncurrent liabilities:13211813761343813
Total liabilities:281248243121776732
Stockholders' equity
Stockholders' equity attributable to parent9711,470464419624213144
Common stock0000000
Additional paid in capital2,2502,1071,4121,017980421279
Accumulated other comprehensive loss(4)(5)(3)(0)(0)(0) 
Accumulated deficit(1,275)(631)(945)(598)(356)(207)(135)
Total stockholders' equity:9711,470464419624213144
Other undisclosed liabilities and equity    1533
TOTAL LIABILITIES AND EQUITY:1,2521,718708540716283179

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues1807946745212811
Cost of revenue(26)(0)     
Cost of goods and services sold(18)(0)     
Gross profit:1547936745212811
Operating expenses(796)(485)(428)(292)(173)(100)(63)
Operating income (loss):(642)309(361)(247)(151)(73)(52)
Nonoperating income (expense)16141030(1)
Other nonoperating income (expense)(1)(0)(0)1031(0)
Interest and debt expense   (0)(0)(0)(1)
Income (loss) from continuing operations before income taxes:(641)315(348)(237)(148)(73)(53)
Income tax expense(3)(1)     
Income (loss) before gain (loss) on sale of properties:(644)314(348)(237)(148)(73)(53)
Other undisclosed net income   00  
Net income (loss):(644)314(348)(237)(148)(73)(53)
Other undisclosed net income attributable to parent     01
Net income (loss) attributable to parent:(644)314(348)(237)(148)(72)(53)
Preferred stock dividends and other adjustments      (3)
Net income (loss) available to common stockholders, diluted:(644)314(348)(237)(148)(72)(56)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(644)314(348)(237)(148)(73)(53)
Other comprehensive income  10   
Comprehensive income (loss):(644)314(347)(237)(148)(73)(53)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(3)(3)(0)(0)0 
Comprehensive income (loss), net of tax, attributable to parent:(643)311(350)(237)(148)(73)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: